Brilliant Violet 421™ anti-human CD105 Antib
- 产品名称：
- Brilliant Violet 421™ anti-human CD105 Antib
- 产品类别：
- 抗体
- 产品编号：
- 323219
- 产品应用：
- 323219
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 2316 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- L-cells transfected with human CD105
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.
Learn more about Brilliant Violet?.
This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents. - Excitation Laser
- Violet Laser (405 nm)
- Application References
(PubMed link indicates BioLegend citation) -
- Bühring HJ, et al. 1991. Leukemia 5:841.
- Vogel W, et al. 2002. Haematologica 88:126.
- Osaka M, et al. 2011. Brain Res. 9:1343. PubMed
- HonMou O, et al. 2011. Brain. 134:1790. PubMed
- Herrera MB, et al. 2013. Hepatology. 57:311. PubMed
- Iohara K, et al. 2014. Exp Gerontol. 52:39. PubMed
- Product Citations
-
- Li Y, et al. 2020. Front Cell Dev Biol. 8:604021. PubMed
- RRID
- AB_2562242 (BioLegend Cat. No. 323219)
- Structure
- Associates with TGF-? receptor I and II, homodimeric type I integral membrane protein, 90 kD
- Distribution
-
Endothelial cells, activated monocytes/macrophages, bone marrow stromal cells, hematopoietic stem/progenitor cells
- Function
- Modulates cellular response to TGF-?, involved in vascular development and remodelling
- Ligand/Receptor
- TGF-?1, TGF-?3
- Cell Type
- Endothelial cells, Hematopoietic stem and progenitors, Macrophages, Mesenchymal Stem Cells, Monocytes
- Biology Area
- Angiogenesis, Cell Biology, Immunology, Stem Cells
- Molecular Family
- Adhesion Molecules, CD Molecules
- Antigen References
-
1. Mason D, et al. Eds. 2002. Leucocyte Typing VII. Oxford University Press. New York.
2. Pierelli L, et al. 2001. Leuk. Lymphoma 42:1195.
- Gene ID
- 2022 View all products for this Gene ID
- UniProt
- View information about CD105 on UniProt.org
